- Home
- CPIX vs RADX Comparison
CPIX vs RADX Comparison
Compare CPIX & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- RADX
- Stock Information
- Founded
- CPIX 1999
- RADX 2021
- Country
- CPIX United States
- RADX Australia
- Employees
- CPIX N/A
- RADX N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- RADX
- Sector
- CPIX Health Care
- RADX
- Exchange
- CPIX Nasdaq
- RADX NYSE
- Market Cap
- CPIX 40.1M
- RADX 32.5M
- IPO Year
- CPIX 2009
- RADX N/A
- Fundamental
- Price
- CPIX $3.52
- RADX $4.71
- Analyst Decision
- CPIX
- RADX Strong Buy
- Analyst Count
- CPIX 0
- RADX 3
- Target Price
- CPIX N/A
- RADX $15.00
- AVG Volume (30 Days)
- CPIX 102.7K
- RADX 17.2K
- Earning Date
- CPIX 08-05-2025
- RADX 02-26-2025
- Dividend Yield
- CPIX N/A
- RADX N/A
- EPS Growth
- CPIX N/A
- RADX N/A
- EPS
- CPIX N/A
- RADX N/A
- Revenue
- CPIX $41,083,299.00
- RADX $204,609.00
- Revenue This Year
- CPIX N/A
- RADX N/A
- Revenue Next Year
- CPIX N/A
- RADX N/A
- P/E Ratio
- CPIX N/A
- RADX N/A
- Revenue Growth
- CPIX 5.82
- RADX N/A
- 52 Week Low
- CPIX $1.04
- RADX $3.50
- 52 Week High
- CPIX $7.25
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- CPIX 47.41
- RADX N/A
- Support Level
- CPIX $3.26
- RADX N/A
- Resistance Level
- CPIX $3.97
- RADX N/A
- Average True Range (ATR)
- CPIX 0.35
- RADX 0.00
- MACD
- CPIX 0.09
- RADX 0.00
- Stochastic Oscillator
- CPIX 53.09
- RADX 0.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.